Patient and family participation in hospice team meeting

患者和家属参加临终关怀团队会议

基本信息

  • 批准号:
    7074959
  • 负责人:
  • 金额:
    $ 13.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-05-03 至 2008-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In congruence with the NCI challenge goal to eliminate suffering due to cancer, and its public health mission related to patient care, this proposal seeks to test a new intervention which will improve the quality of care at the end of life and quality of life for dying cancer patients and family. This project proposes to strengthen hospice care for cancer patients by enabling patient/family participation in hospice interdisciplinary teams (IDTs) through use of a commercially available videophone. The overall purpose of this exploratory project is to test an intervention to improve end of life care by involving cancer patients and family caregivers in hospice IDT meetings. The hypothesis is that the active participation of cancer patients and their primary family caregiver in the hospice IDT meeting will improve communication, pain management and quality of life. The exploratory study will allow for testing of the intervention logistics, identifying sampling and recruitment issues, assessing the qualitative methodology, and testing of specific instruments. The study aims to:1) use observation and interviews to explore communication between the team and patient/family, 2) test measures to assess changes in pain and symptom management, and 3) test measures to assess changes in quality of life. The theoretical model developed by Saltz and Schaefer advocate the assessment of the IDT context, process, structure, and outcomes as a foundation for involving patients and families in the IDT. This exploratory intervention uses a quasi-experimental design in a sequential two-phase mixed methods approach involving qualitative and quantitative methods in parallel and equal status. The qualitative design includes observations of team meetings and interviews with family members. The quantitative component uses previously used instruments to measure the outcomes of participation in IDT meetings. Phase I involves the observation and measurement of hospice cancer patients who are not involved in the IDT meeting to serve as a comparison group. Phase II introduces the videophone as a tool to support patient and family involvement in the IDT meeting. The results of this study will provide preliminary data for a larger multi-phase, multi-site follow-up project.
描述(由申请人提供):与NCI消除癌症痛苦的挑战目标及其与患者护理相关的公共卫生使命一致,本提案旨在测试一种新的干预措施,该干预措施将改善临终时的护理质量和临终癌症患者及其家人的生活质量。本项目旨在通过使用商用可视电话,使患者/家属能够参与临终关怀跨学科团队(IDT),从而加强对癌症患者的临终关怀。这个探索性项目的总体目的是测试一种干预措施,通过让癌症患者和家庭护理人员参加临终关怀IDT会议来改善临终关怀。假设癌症患者和他们的主要家庭照顾者积极参与临终关怀IDT会议将改善沟通,疼痛管理和生活质量。探索性研究将允许对干预后勤进行测试,确定抽样和招募问题,评估定性方法,并测试特定工具。该研究旨在:1)使用观察和访谈来探索团队与患者/家属之间的沟通,2)测试措施来评估疼痛和症状管理的变化,3)测试措施来评估生活质量的变化。Saltz和Schaefer开发的理论模型主张对IDT背景、过程、结构和结果进行评估,作为让患者和家属参与IDT的基础。这种探索性干预采用准实验设计,采用连续两阶段混合方法,包括平行和平等地位的定性和定量方法。定性设计包括观察团队会议和家庭成员访谈。定量部分使用以前使用的工具来衡量参加IDT会议的成果。第一阶段是对没有参加IDT会议的临终关怀癌症患者进行观察和测量,作为对照组。第二阶段引入可视电话作为支持患者和家属参与IDT会议的工具。本研究的结果将为更大规模的多阶段、多中心随访项目提供初步数据。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Debra Parker Oliver其他文献

Debra Parker Oliver的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Debra Parker Oliver', 18)}}的其他基金

Caregiver Speaks: A Technologically Mediated Storytelling Intervention for Family Caregivers ofIndividuals with Alzheimer's Disease and Other Dementias
照顾者说话:针对患有阿尔茨海默病和其他痴呆症的家庭照顾者的技术介导的讲故事干预
  • 批准号:
    10470920
  • 财政年份:
    2020
  • 资助金额:
    $ 13.97万
  • 项目类别:
Caregiver Speaks: A Technologically Mediated Storytelling Intervention for Family Caregivers ofIndividuals with Alzheimer's Disease and Other Dementias
照顾者说话:针对患有阿尔茨海默病和其他痴呆症的家庭照顾者的技术介导的讲故事干预
  • 批准号:
    10543131
  • 财政年份:
    2020
  • 资助金额:
    $ 13.97万
  • 项目类别:
Caregiver Speaks: A Technologically Mediated Storytelling Intervention for Family Caregivers ofIndividuals with Alzheimer's Disease and Other Dementias
照顾者说话:针对患有阿尔茨海默病和其他痴呆症的家庭照顾者的技术介导的讲故事干预
  • 批准号:
    10329148
  • 财政年份:
    2020
  • 资助金额:
    $ 13.97万
  • 项目类别:
ACCESS_Access for Cancer Caregivers to Education and Support for Shared decision-making
ACCESS_癌症护理人员获得教育和共同决策支持的机会
  • 批准号:
    9412445
  • 财政年份:
    2017
  • 资助金额:
    $ 13.97万
  • 项目类别:
ACCESS_Access for Cancer Caregivers to Education and Support for Shared decisionmaking
ACCESS_癌症护理人员获得教育和共同决策支持的机会
  • 批准号:
    10307956
  • 财政年份:
    2017
  • 资助金额:
    $ 13.97万
  • 项目类别:
Shared Decision Making to Improve Palliative Care in the Nursing Home
共同决策以改善疗养院的姑息治疗
  • 批准号:
    9355095
  • 财政年份:
    2016
  • 资助金额:
    $ 13.97万
  • 项目类别:
The ACTIVE Intervention to Improve Hospice Caregiver Pain Management
改善临终关怀护理人员疼痛管理的积极干预措施
  • 批准号:
    7986283
  • 财政年份:
    2010
  • 资助金额:
    $ 13.97万
  • 项目类别:
The ACTIVE Intervention to Improve Hospice Caregiver Pain Management
改善临终关怀护理人员疼痛管理的积极干预措施
  • 批准号:
    8487258
  • 财政年份:
    2010
  • 资助金额:
    $ 13.97万
  • 项目类别:
The ACTIVE Intervention to Improve Hospice Caregiver Pain Management
改善临终关怀护理人员疼痛管理的积极干预措施
  • 批准号:
    8142959
  • 财政年份:
    2010
  • 资助金额:
    $ 13.97万
  • 项目类别:
The ACTIVE Intervention to Improve Hospice Caregiver Pain Management
改善临终关怀护理人员疼痛管理的积极干预措施
  • 批准号:
    8300225
  • 财政年份:
    2010
  • 资助金额:
    $ 13.97万
  • 项目类别:

相似海外基金

The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 13.97万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 13.97万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 13.97万
  • 项目类别:
University of Colorado Rocky Mountain NeuroNEXT (UNCOMON) Clinical Research Consortium.
科罗拉多大学落基山 NeuroNEXT (UNCOMON) 临床研究联盟。
  • 批准号:
    10744629
  • 财政年份:
    2023
  • 资助金额:
    $ 13.97万
  • 项目类别:
User-centered approach to the development of a parent toolkit to improve willingness to participate in pediatric clinical research
以用户为中心的方法开发家长工具包,以提高参与儿科临床研究的意愿
  • 批准号:
    10663456
  • 财政年份:
    2023
  • 资助金额:
    $ 13.97万
  • 项目类别:
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) - COVAIL DMID #22-0004
传染病临床研究联盟领导小组 (IDCRCLG) - COVAIL DMID
  • 批准号:
    10615472
  • 财政年份:
    2022
  • 资助金额:
    $ 13.97万
  • 项目类别:
Clinical Research & Patient Care Core (CRPCC)
临床研究
  • 批准号:
    10431471
  • 财政年份:
    2022
  • 资助金额:
    $ 13.97万
  • 项目类别:
Clinical Research & Patient Care Core (CRPCC)
临床研究
  • 批准号:
    10588232
  • 财政年份:
    2022
  • 资助金额:
    $ 13.97万
  • 项目类别:
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
传染病临床研究联盟领导小组 (IDCRCLG)
  • 批准号:
    10462071
  • 财政年份:
    2021
  • 资助金额:
    $ 13.97万
  • 项目类别:
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
传染病临床研究联盟领导小组 (IDCRCLG)
  • 批准号:
    10462061
  • 财政年份:
    2021
  • 资助金额:
    $ 13.97万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了